carboplatin
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
17 FDA-registered drug labelers
Accord Healthcare, Inc.
Apotex Corp.
Avyxa Pharma, LLC
BPI Labs LLC
Cipla Ltd.
Eugia US LLC
Fresenius Kabi USA, LLC
Gland Pharma Limited
Heraeus Precious Metals GmbH & Co. KG
Hetero Labs Limited
Hospira, Inc.
Sicor de Mexico S.A. de C.V
SUN PHARMACEUTICAL INDUSTRIES, INC.
Teva Parenteral Medicines, Inc.
Teyro Labs Private Limited
Umicore Agrentina s.A.
Veranova, L.P.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Carboplatin
- •Kyxata
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Carboplatin Injection
04/28/2023Limited Availability
current
Carboplatin Injection
04/28/2023Unavailable
current
Carboplatin Injection
04/28/2023Available
to be discontinued
Carboplatin Injection
02/20/2026Chemical Identity
CAS41575-94-4
PubChem CID426756
DTXSIDDTXSID3046742
FormulaC6H12N2O4Pt
Mol. Weight371.25 g/mol
SMILESC1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2]
Data Sources
4267562026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/carboplatin/cids/JSON
Archive: data/sources/pubchem_name/carboplatin.json
CAS 41575-94-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 41575-94-42026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json